Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$1.39 - $3.12 $31,647 - $71,036
-22,768 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.6 - $4.17 $7,020 - $11,259
-2,700 Reduced 10.6%
22,768 $69,000
Q4 2021

Feb 11, 2022

BUY
$3.64 - $7.78 $4,884 - $10,440
1,342 Added 5.56%
25,468 $93,000
Q3 2021

Nov 04, 2021

SELL
$6.01 - $8.71 $4,669 - $6,767
-777 Reduced 3.12%
24,126 $190,000
Q2 2021

Aug 11, 2021

BUY
$6.02 - $9.64 $9,132 - $14,623
1,517 Added 6.49%
24,903 $181,000
Q1 2021

May 13, 2021

SELL
$9.17 - $14.8 $44,621 - $72,016
-4,866 Reduced 17.22%
23,386 $0
Q4 2020

Feb 16, 2021

SELL
$8.92 - $13.29 $5,708 - $8,505
-640 Reduced 2.22%
28,252 $319,000
Q3 2020

Nov 12, 2020

BUY
$9.94 - $16.59 $99,817 - $166,596
10,042 Added 53.27%
28,892 $309,000
Q2 2020

Aug 13, 2020

BUY
$12.07 - $19.34 $121,653 - $194,927
10,079 Added 114.91%
18,850 $286,000
Q1 2020

May 14, 2020

SELL
$12.5 - $22.04 $4,662 - $8,220
-373 Reduced 4.08%
8,771 $137,000
Q4 2019

Feb 14, 2020

BUY
$11.42 - $22.19 $23,490 - $45,644
2,057 Added 29.02%
9,144 $188,000
Q3 2019

Nov 14, 2019

SELL
$14.74 - $22.28 $82,219 - $124,277
-5,578 Reduced 44.04%
7,087 $127,000
Q2 2019

Aug 14, 2019

SELL
$18.35 - $30.34 $126,174 - $208,617
-6,876 Reduced 35.19%
12,665 $247,000
Q1 2019

May 15, 2019

BUY
$19.76 - $29.57 $13,100 - $19,604
663 Added 3.51%
19,541 $539,000
Q4 2018

Feb 14, 2019

SELL
$18.39 - $26.3 $93,752 - $134,077
-5,098 Reduced 21.26%
18,878 $420,000
Q3 2018

Dec 21, 2021

BUY
$15.54 - $22.86 $42,766 - $62,910
2,752 Added 12.97%
23,976 $549,000
Q3 2018

Nov 14, 2018

BUY
$15.54 - $22.86 $13,581 - $19,979
874 Added 4.29%
21,224 $483,000
Q2 2018

Apr 21, 2020

BUY
$16.49 - $21.55 $55,901 - $73,054
3,390 Added 19.99%
20,350 $415,000
Q2 2018

Aug 14, 2018

BUY
$16.49 - $21.55 $279,670 - $365,488
16,960 New
16,960 $345,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.